Burkholderia cepacia Produces a Hemolysin That Is Capable of Inducing Apoptosis and Degranulation of Mammalian Phagocytes

ABSTRACT Burkholderia cepacia is an opportunistic pathogen that has become a major threat to individuals with cystic fibrosis (CF). In approximately 20% of patients, pulmonary colonization with B. cepacia leads to cepacia syndrome, a fatal fulminating pneumonia sometimes associated with septicemia. It has been reported that culture filtrates of clinically derived strains of B. cepacia are hemolytic. In this study, we have characterized a factor which contributes to this hemolytic activity and is secreted from B. cepacia J2315, a representative of the virulent and highly transmissible strain belonging to the recently described genomovar III grouping. Biochemical data from the described purification method for this hemolysin allows us to hypothesize that the toxin is a lipopeptide. As demonstrated for other lipopeptide toxins, the hemolysin from B. cepacia was surface active and lowered the surface tension of high-pressure liquid chromatography-grade water from 72.96 to 29.8 mN m−1. Similar to reports for other pore-forming cytotoxins, low concentrations of the hemolysin were able to induce nucleosomal degradation consistent with apoptosis in human neutrophils and the mouse-derived macrophage-type cell line J774.2. Exposure of human neutrophils to higher concentrations of toxin resulted in increased activities of the neutrophil degranulation markers cathepsin G and elastase. Based on the results obtained in this study, we suggest a role that allows B. cepacia to thwart the immune response and a model of the events that may contribute to the severe inflammatory response in the lungs of CF patients.

[1]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[2]  K. Johnstone,et al.  Evidence for the involvement of the surface active properties of the extracellular toxin tolaasin in the manifestation of brown blotch disease symptoms by Pseudomonas tolaasii on Agaricus bisporus , 1993 .

[3]  J. Govan,et al.  Virulence factors of Burkholderia cepacia. , 1994, FEMS immunology and medical microbiology.

[4]  S. Bhakdi,et al.  Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation , 1994, Infection and immunity.

[5]  M. Kaufmann,et al.  Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. , 1996, Journal of medical microbiology.

[6]  M. Dodd,et al.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis , 1993, The Lancet.

[7]  A. Zychlinsky,et al.  Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin , 1993, Infection and immunity.

[8]  E. Greenberg,et al.  Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid , 1996, Cell.

[9]  M E Campbell,et al.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting , 1996, Journal of clinical microbiology.

[10]  L. Tsui,et al.  Identification of the cystic fibrosis gene: chromosome walking and jumping. , 1989, Science.

[11]  P. Vandamme,et al.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. , 1997, International journal of systematic bacteriology.

[12]  T. Nakazawa,et al.  Characterization of Hemolytic and Antifungal Substance, Cepalycin, from Pseudomonas cepacia , 1994, Microbiology and immunology.

[13]  William D. Harkins,et al.  THE DETERMINATION OF SURFACE TENSION (FREE SURFACE ENERGY), AND THE WEIGHT OF FALLING DROPS: THE SURFACE TENSION OF WATER AND BENZENE BY THE CAPILLARY HEIGHT METHOD. , 1919 .

[14]  M. Tester,et al.  Role of biosurfactant and ion channel-forming activities of syringomycin in transmembrane ion flux: a model for the mechanism of action in the plant-pathogen interaction. , 1995, Molecular plant-microbe interactions : MPMI.

[15]  D. Woods,et al.  Purification and characterization of an extracellular protease from Pseudomonas cepacia , 1989, Infection and immunity.

[16]  A. Prince,et al.  Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Yamada,et al.  Characterization of hemolysin in extracellular products of Pseudomonas cepacia , 1987, Journal of clinical microbiology.

[18]  M. Robert-Gero,et al.  The aspartate kinase of Pseudomonas putida. Regulation of synthesis and activity. , 1970, Biochimica et biophysica acta.

[19]  R. Stern,et al.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. , 1985, The American review of respiratory disease.

[20]  S. Fitzsimmons,et al.  Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. , 1996, Journal of pediatric gastroenterology and nutrition.

[21]  M. Riley,et al.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain , 1995, Nature Medicine.

[22]  P. Vandamme,et al.  Burkholderia cepacia: medical, taxonomic and ecological issues. , 1996, Journal of medical microbiology.

[23]  D. Gross,et al.  Lipopeptide phytotoxins produced by Pseudomonas syringae pv. syringae: comparison of the biosurfactant and ion channel-forming activities of syringopeptin and syringomycin. , 1997, Molecular plant-microbe interactions : MPMI.

[24]  P. Quinton,et al.  Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding , 1992, Nature.

[25]  S. Tyler,et al.  Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping , 1994, Journal of clinical microbiology.

[26]  S. de Bentzmann,et al.  Pseudomonas aeruginosa adherence to remodelling respiratory epithelium. , 1996, The European respiratory journal.

[27]  F. Sylvester,et al.  Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors , 1996, Infection and immunity.

[28]  J. Govan,et al.  Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. , 1995, FEMS immunology and medical microbiology.

[29]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.

[30]  D. Goldmann,et al.  Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. , 1986, The Journal of pediatrics.

[31]  A. Ghoneim,et al.  Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. , 1990, Archives of disease in childhood.

[32]  P. Vandamme,et al.  Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. , 1996, Acta clinica Belgica.

[33]  R. Palfreyman,et al.  Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products , 1997, Infection and immunity.

[34]  M. Vasil,et al.  Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia , 1990, Infection and immunity.

[35]  T. Pitt,et al.  Burkholderia (Pseudomonas) cepacia: pathogenicity and resistance , 1995 .

[36]  M. Corey,et al.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. , 1984, The Journal of pediatrics.

[37]  P. Gilligan,et al.  Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.

[38]  E. Chi,et al.  Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia , 1996, Infection and immunity.